PHARMCONSULT AS
Operating
Konsulent- og rådgivningstjenester innen farmasi, helsekost og
næringsmidler eller relaterte områder, investeringer i verdipapirer og
eiendom, samt å delta i andre aktiviteter av beslektet karakter.
Bedriftsrådgivning og annen administrativ rådgivning.
Links
Organization
- CEO
- Chairman of the board
- Years since formation
- 19 years
- since Apr 16, 2007
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 1,783,793
- NOK
- Annual total result 2025
- 307,313
- NOK
- Total equity 2025
- 7,517,210
- NOK
Last update: Jun 16, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | 100 % directly | |
TH | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1,000 | 100 % |
Shares owned by the PHARMCONSULT AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 750 | 33.33 % | |
| Ordinary shares | 20,600 | 1.22 % | |
| Ordinary shares | 111 | 0.5 % | |
| Ordinary shares | 5,600 | 0.44 % | |
| NO0012753625 | 30,000 | 0.04 % | |
| Ordinary shares | 2,000 | 0.04 % | |
| NO0010205966 | 2,610 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 1,783,793 | 3,596,263 | 4,096,867 | 4,153,857 | 4,566,630 |
Annual Total Result | 307,313 | 1,358,067 | 1,102,321 | 1,597,598 | 2,054,367 |
Total assets | 7,995,031 | 8,330,743 | 8,252,944 | 8,030,676 | 6,718,743 |
Total liabilities | 477,821 | 1,120,845 | 2,401,114 | 3,050,614 | 3,336,280 |
Total equity | 7,517,210 | 7,209,898 | 5,851,830 | 4,980,061 | 3,382,463 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 1,783,793 | 3,596,263 | 4,096,867 | 4,153,857 | 4,566,630 |
Total operating costs | 1,580,808 | 1,961,158 | 2,662,395 | 2,083,979 | 1,930,616 |
Operating result | 202,985 | 1,635,105 | 1,434,473 | 2,069,877 | 2,636,013 |
Financial income/costs | 148,014 | 67,205 | -4,003 | -21,524 | -9,645 |
Profit before tax | 350,999 | 1,702,310 | 1,430,470 | 2,048,353 | 2,626,369 |
Total tax & extraordinary income/cost | 43,686 | 344,243 | 328,149 | 450,755 | 572,002 |
Annual Total Result | 307,313 | 1,358,067 | 1,102,321 | 1,597,598 | 2,054,367 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 5,730,691 | 5,148,291 | 5,143,423 | 4,485,878 | 4,233,878 |
Total current assets | 2,264,340 | 3,182,451 | 3,109,521 | 3,544,797 | 2,484,864 |
Total assets | 7,995,031 | 8,330,743 | 8,252,944 | 8,030,676 | 6,718,743 |
Short term debt | 477,821 | 888,008 | 1,417,669 | 1,361,966 | 1,391,418 |
Long term debt | 0 | 232,837 | 983,444 | 1,688,649 | 1,944,862 |
Total liabilities | 477,821 | 1,120,845 | 2,401,114 | 3,050,614 | 3,336,280 |
Contributed capital | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
Retained earnings | 7,417,210 | 7,109,898 | 5,751,830 | 4,880,061 | 3,282,463 |
Total equity | 7,517,210 | 7,209,898 | 5,851,830 | 4,980,061 | 3,382,463 |
Total equity and liabilities | 7,995,031 | 8,330,743 | 8,252,944 | 8,030,676 | 6,718,743 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises